Cargando…
Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
BACKGROUND: Simple, robust, sensitive and clinically meaningful outcome measures are required for neuroprotective trials in Parkinson's disease (PD). We explored the feasibility of a composite binary outcome measure, ‘dead or dependent’, in such trials using data from a prospective follow-up st...
Autores principales: | McGhee, David, Parker, Alexander, Fielding, Shona, Zajicek, John, Counsell, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316847/ https://www.ncbi.nlm.nih.gov/pubmed/24854405 http://dx.doi.org/10.1136/jnnp-2014-307703 |
Ejemplares similares
-
A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022) -
The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016) -
Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson’s
por: Chivers Seymour, Kim, et al.
Publicado: (2019) -
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018) -
From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease
por: Bloem, Bastiaan R., et al.
Publicado: (2020)